Reports
Reports
Increase in prevalence of chronic and infectious diseases, the need for advanced diagnostic tools, and technological advancements, are fueling the in vitro diagnostics (IVD) market size. Furthermore, the demand for accurate and efficient diagnostics is expected to drive market progress.
Technological advancements in IVD spurs the introduction of innovative products and services, enhancing diagnostic capabilities and enabling the development of new diagnostic methods.
Growth in awareness among patients and healthcare professionals about the importance of early and accurate diagnosis is also expected to bolster the in vitro diagnostics market growth.
Increase in focus on healthcare spending and investments in research and development activities by both public and private sectors are likely to further propel the growth of the in vitro diagnostics market.
The in vitro diagnostics market is rapidly growing and encompasses products and services for testing bodily samples outside the body to facilitate medical diagnoses. In terms of product & service, the market can be divided into three categories: reagents & kits, instruments, and software & services.
Reagents & kits are essential components used in diagnostic tests, while instruments are physical tools required for accurate and efficient testing. Software & services play a crucial role in data management, analysis, and reporting of test results.
The market is characterized by diverse technologies such as immunoassay, clinical chemistry, molecular diagnostics, blood glucose monitoring, and hematology, catering to various medical needs. Clinical chemistry methods analyze blood and bodily fluids to assess chemical components.
Molecular diagnostics examine genetic material to detect diseases at a molecular level, providing valuable insights into personalized healthcare. Blood glucose monitoring is crucial for managing diabetes, while hematology focuses on blood-related disorders and abnormalities, offering diagnostic tools for conditions including anemia and leukemia.
The in vitro diagnostics market serves a wide range of end-users, including diagnostic centers, hospital-based laboratories, academic & research institutes, home care services, and other healthcare providers.
This diverse range of end-users highlights the widespread impact and importance of the in-vitro diagnostics market in the healthcare ecosystem.
| Attribute | Detail |
|---|---|
| Drivers |
|
In vitro diagnostics (IVDs) play a significant role in healthcare, contributing to 70% of clinical decisions. Technological advancements, such as 3D printing and genomics, have improved diagnostic capabilities.
Predictive biomarkers assist physicians in predicting drug responses and optimizing treatment plans. Point-of-care testing (POCT) offers faster turnaround times and lower costs. Microfluidics, utilizing materials such as PDMS, provide low-volume analysis, high-throughput, automation, and portability.
Innovative technologies such as RT-PCR and next-generation sequencing offer cost-effective diagnosis, prognosis, and therapy selection. Thus, rapid advancements in technology is expected to bolster the in vitro diagnostics industry growth.
The rise of personalized medicine is an innovative approach that tailors medical treatments to individual patients, considering factors such as genetics, lifestyle, and environment.
Personalized medicine has surged the demand for advanced diagnostic solutions, especially in oncology, where genetic and molecular profiling helps identify tumor biomarkers. Technological advancements including Next-Generation Sequencing (NGS) contribute to disease diagnosis and treatment selection.
Companion diagnostics, which identify patients likely to benefit from specific therapies is a key factor driving the in vitro diagnostics market value. As healthcare shifts toward patient-centric approaches, the IVD industry plays a crucial role in shaping personalized medicine.
The in vitro diagnostics market is expanding due to patient preference for testing at physician's clinics or homes (point-of-care testing). Intersegment substitution, such as molecular point-of-care diagnostics, is further accelerating market development.
Companies including Autonomous Medical Devices Incorporated (AMDI) and Proxim Diagnostics are developing innovative systems for rapid, accurate testing.
AMDI received a US$ 5.3 Mn grant to create a fast PCR system detecting multiple targets, while Proxim secured investment for its portable immunodiagnostic device.
The Covid-19 pandemic further increased the importance of point-of-care diagnostics, with the market projected to reach US$ 38.5 Bn by 2030.
The in vitro diagnostics market segmentation by product & service includes reagents & kits, instruments, and software & services. The reagents segment dominated the market in 2022.
The large-scale requirements of diagnostic labs, research centers, and Contract Research Organizations (CROs) is leading to the dominance of reagents & kits. The surge in demand for in vitro assays in pathological analysis and the continuous advancements in diagnostic techniques are also major market catalysts.
Furthermore, expansion of the reagents segment and ongoing technological developments within the industry are expected to offer lucrative in vitro diagnostics market opportunities.
The in vitro diagnostics industry report reveals that the market is likely to flourish in the near future due to advancements in technology and increasing prevalence of chronic disorders and infectious diseases.
Based on technology, the clinical chemistry segment's dominance in the market highlights its significance in disease diagnosis and patient management across various healthcare settings. The segment's growth is driven by the continuous development of innovative diagnostic tools and techniques.
Growth of the immunoassay segment is attributed to the extensive research and development activities that are being carried out in this field, leading to the launch of more accurate and efficient diagnostic tests.
The molecular diagnostics segment also is poised for significant expansion during the forecast period, credited to the rise in prevalence of chronic disorders and infectious diseases, which necessitates the development of advanced diagnostic methods to accurately identify and manage these conditions.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest in vitro diagnostics market forecast, North America dominated the global industry in 2022. A robust healthcare infrastructure, high healthcare expenditure, and strong government support for research and development creates a favorable environment for the industry in the region.
Furthermore, the presence of major IVD companies and technological advancements boosts market dynamics in the region.
The large patient population, surge in demand for advanced diagnostic technologies, and rise in prevalence of chronic diseases further drives market statistics, ensuring North America's leading position in the IVD market.
Leading players have adopted strategies such as development of diagnostic kits and launching new kits to increase their in vitro diagnostics market share.
Danaher Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton, Dickinson, and Company, QIAGEN N.V., bioMérieux SA, Siemens Healthineers, Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Chembio Diagnostics, Inc., Sysmex Corporation, QuidelOrtho Corporation, and Illumina, Inc. are the prominent in vitro diagnostics market manufacturers.
Key players have been profiled in the global in vitro diagnostics market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 | US$ 91.2 Bn |
| Forecast (Value) in 2031 | US$ 119.7 Bn |
| Growth Rate (CAGR) | 5.3% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It provides segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 91.2 Bn in 2022
It is projected to reach more than US$ 119.7 Bn by the end of 2031
The CAGR is projected to be 5.3% from 2023 to 2031
Increase in incidence and prevalence of chronic disease and advanced diagnostic technology
North America is projected to account for major share during the forecast period
Danaher Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton, Dickinson, and Company, QIAGEN N.V., bioMérieux SA, Siemens Healthineers, Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Chembio Diagnostics, Inc., Sysmex Corporation, QuidelOrtho Corporation, and Illumina, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In Vitro Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In Vitro Diagnostics Market Analysis and Forecasts, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario
5.3. Price Analysis
5.4. Top Player Positioning
5.5. Covid-19 Pandemic Impact on Industry
6. Global In Vitro Diagnostics Market Analysis and Forecasts, By Product & Service
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product & Service, 2017-2031
6.3.1. Reagents & Kits
6.3.2. Instruments
6.3.3. Software & Services
6.4. Market Attractiveness By Product & Service
7. Global In Vitro Diagnostics Market Analysis and Forecasts, By Technology
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Technology, 2017-2031
7.3.1. Clinical Chemistry
7.3.1.1. Metabolic Panel
7.3.1.2. Electrolyte Panel
7.3.1.3. Liver Panel
7.3.1.4. Lipid Profile
7.3.1.5. Renal Profile
7.3.1.6. Thyroid Function Panel
7.3.2. Immunoassay
7.3.2.1. ELISA
7.3.2.2. ELISPOT
7.3.2.3. Rapid Test
7.3.2.4. Others
7.3.3. Molecular Diagnostics
7.3.3.1. PCR
7.3.3.2. Isothermal Nucleic Acid Amplification Technology
7.3.3.3. Microarray
7.3.3.4. Hybridization
7.3.3.5. DNA Sequencing & Next-Generation Sequencing
7.3.4. Blood Glucose Monitoring
7.3.5. Hematology
7.3.6. Others (Mass Spectrometry, etc.)
7.4. Market Attractiveness By Technology
8. Global In Vitro Diagnostics Market Analysis and Forecasts, By Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Application, 2017-2031
8.3.1. Oncology
8.3.2. Infectious Diseases
8.3.3. Metabolic Diseases
8.3.4. Cardiology
8.3.5. Nephrology
8.3.6. Drug Testing/pharmacogenomics
8.3.7. Autoimmune Diseases
8.3.8. Others
8.4. Market Attractiveness By Application
9. Global In Vitro Diagnostics Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2017-2031
9.3.1. Diagnostic Centers
9.3.2. Hospital-based Laboratories
9.3.3. Academic & Research Institutes
9.3.4. Home care
9.3.5. Others
9.4. Market Attractiveness By End-user
10. Global In Vitro Diagnostics Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America In Vitro Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product & Service, 2017-2031
11.2.1. Reagents & Kits
11.2.2. Instruments
11.2.3. Software & Services
11.3. Market Value Forecast By Technology, 2017-2031
11.3.1. Clinical Chemistry
11.3.1.1. Metabolic Panel
11.3.1.2. Electrolyte Panel
11.3.1.3. Liver Panel
11.3.1.4. Lipid Profile
11.3.1.5. Renal Profile
11.3.1.6. Thyroid Function Panel
11.3.2. Immunoassay
11.3.2.1. ELISA
11.3.2.2. ELISPOT
11.3.2.3. Rapid Test
11.3.2.4. Others
11.3.3. Molecular Diagnostics
11.3.3.1. PCR
11.3.3.2. Isothermal Nucleic Acid Amplification Technology
11.3.3.3. Microarray
11.3.3.4. Hybridization
11.3.3.5. DNA Sequencing & Next-Generation Sequencing
11.3.4. Blood Glucose Monitoring
11.3.5. Hematology
11.3.6. Others (Mass Spectrometry, etc.)
11.4. Market Value Forecast By Application, 2017-2031
11.4.1. Oncology
11.4.2. Infectious Diseases
11.4.3. Metabolic Diseases
11.4.4. Cardiology
11.4.5. Nephrology
11.4.6. Drug Testing/pharmacogenomics
11.4.7. Autoimmune Diseases
11.4.8. Others
11.5. Market Value Forecast By End-user, 2017-2031
11.5.1. Diagnostic Centers
11.5.2. Hospital-based Laboratories
11.5.3. Academic & Research Institutes
11.5.4. Home care
11.5.5. Others
11.6. Market Value Forecast By Country/Sub-region, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product & Service
11.7.2. By Technology
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country/Sub-region
12. Europe In Vitro Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product & Service, 2017-2031
12.2.1. Reagents & Kits
12.2.2. Instruments
12.2.3. Software & Services
12.3. Market Value Forecast By Technology, 2017-2031
12.3.1. Clinical Chemistry
12.3.1.1. Metabolic Panel
12.3.1.2. Electrolyte Panel
12.3.1.3. Liver Panel
12.3.1.4. Lipid Profile
12.3.1.5. Renal Profile
12.3.1.6. Thyroid Function Panel
12.3.2. Immunoassay
12.3.2.1. ELISA
12.3.2.2. ELISPOT
12.3.2.3. Rapid Test
12.3.2.4. Others
12.3.3. Molecular Diagnostics
12.3.3.1. PCR
12.3.3.2. Isothermal Nucleic Acid Amplification Technology
12.3.3.3. Microarray
12.3.3.4. Hybridization
12.3.3.5. DNA Sequencing & Next-Generation Sequencing
12.3.4. Blood Glucose Monitoring
12.3.5. Hematology
12.3.6. Others (Mass Spectrometry, etc.)
12.4. Market Value Forecast By Application, 2017-2031
12.4.1. Oncology
12.4.2. Infectious Diseases
12.4.3. Metabolic Diseases
12.4.4. Cardiology
12.4.5. Nephrology
12.4.6. Drug Testing/pharmacogenomics
12.4.7. Autoimmune Diseases
12.4.8. Others
12.5. Market Value Forecast By End-user, 2017-2031
12.5.1. Diagnostic Centers
12.5.2. Hospital-based Laboratories
12.5.3. Academic & Research Institutes
12.5.4. Home care
12.5.5. Others
12.6. Market Value Forecast By Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product & Service
12.7.2. By Technology
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product & Service, 2017-2031
13.2.1. Reagents & Kits
13.2.2. Instruments
13.2.3. Software & Services
13.3. Market Value Forecast By Technology, 2017-2031
13.3.1. Clinical Chemistry
13.3.1.1. Metabolic Panel
13.3.1.2. Electrolyte Panel
13.3.1.3. Liver Panel
13.3.1.4. Lipid Profile
13.3.1.5. Renal Profile
13.3.1.6. Thyroid Function Panel
13.3.2. Immunoassay
13.3.2.1. ELISA
13.3.2.2. ELISPOT
13.3.2.3. Rapid Test
13.3.2.4. Others
13.3.3. Molecular Diagnostics
13.3.3.1. PCR
13.3.3.2. Isothermal Nucleic Acid Amplification Technology
13.3.3.3. Microarray
13.3.3.4. Hybridization
13.3.3.5. DNA Sequencing & Next-Generation Sequencing
13.3.4. Blood Glucose Monitoring
13.3.5. Hematology
13.3.6. Others (Mass Spectrometry, etc.)
13.4. Market Value Forecast By Application, 2017-2031
13.4.1. Oncology
13.4.2. Infectious Diseases
13.4.3. Metabolic Diseases
13.4.4. Cardiology
13.4.5. Nephrology
13.4.6. Drug Testing/pharmacogenomics
13.4.7. Autoimmune Diseases
13.4.8. Others
13.5. Market Value Forecast By End-user, 2017-2031
13.5.1. Diagnostic Centers
13.5.2. Hospital-based Laboratories
13.5.3. Academic & Research Institutes
13.5.4. Home care
13.5.5. Others
13.6. Market Value Forecast By Country/Sub-region, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product & Service
13.7.2. By Technology
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America In Vitro Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product & Service, 2017-2031
14.2.1. Reagents & Kits
14.2.2. Instruments
14.2.3. Software & Services
14.3. Market Value Forecast By Technology, 2017-2031
14.3.1. Clinical Chemistry
14.3.1.1. Metabolic Panel
14.3.1.2. Electrolyte Panel
14.3.1.3. Liver Panel
14.3.1.4. Lipid Profile
14.3.1.5. Renal Profile
14.3.1.6. Thyroid Function Panel
14.3.2. Immunoassay
14.3.2.1. ELISA
14.3.2.2. ELISPOT
14.3.2.3. Rapid Test
14.3.2.4. Others
14.3.3. Molecular Diagnostics
14.3.3.1. PCR
14.3.3.2. Isothermal Nucleic Acid Amplification Technology
14.3.3.3. Microarray
14.3.3.4. Hybridization
14.3.3.5. DNA Sequencing & Next-Generation Sequencing
14.3.4. Blood Glucose Monitoring
14.3.5. Hematology
14.3.6. Others (Mass Spectrometry, etc.)
14.4. Market Value Forecast By Application, 2017-2031
14.4.1. Oncology
14.4.2. Infectious Diseases
14.4.3. Metabolic Diseases
14.4.4. Cardiology
14.4.5. Nephrology
14.4.6. Drug Testing/pharmacogenomics
14.4.7. Autoimmune Diseases
14.4.8. Others
14.5. Market Value Forecast By End-user, 2017-2031
14.5.1. Diagnostic Centers
14.5.2. Hospital-based Laboratories
14.5.3. Academic & Research Institutes
14.5.4. Home care
14.5.5. Others
14.6. Market Value Forecast By Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product & Service
14.7.2. By Technology
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product & Service, 2017-2031
15.2.1. Reagents & Kits
15.2.2. Instruments
15.2.3. Software & Services
15.3. Market Value Forecast By Technology, 2017-2031
15.3.1. Clinical Chemistry
15.3.1.1. Metabolic Panel
15.3.1.2. Electrolyte Panel
15.3.1.3. Liver Panel
15.3.1.4. Lipid Profile
15.3.1.5. Renal Profile
15.3.1.6. Thyroid Function Panel
15.3.2. Immunoassay
15.3.2.1. ELISA
15.3.2.2. ELISPOT
15.3.2.3. Rapid Test
15.3.2.4. Others
15.3.3. Molecular Diagnostics
15.3.3.1. PCR
15.3.3.2. Isothermal Nucleic Acid Amplification Technology
15.3.3.3. Microarray
15.3.3.4. Hybridization
15.3.3.5. DNA Sequencing & Next-Generation Sequencing
15.3.4. Blood Glucose Monitoring
15.3.5. Hematology
15.3.6. Others (Mass Spectrometry, etc.)
15.4. Market Value Forecast By Application, 2017-2031
15.4.1. Oncology
15.4.2. Infectious Diseases
15.4.3. Metabolic Diseases
15.4.4. Cardiology
15.4.5. Nephrology
15.4.6. Drug Testing/pharmacogenomics
15.4.7. Autoimmune Diseases
15.4.8. Others
15.5. Market Value Forecast By End-user, 2017-2031
15.5.1. Diagnostic Centers
15.5.2. Hospital-based Laboratories
15.5.3. Academic & Research Institutes
15.5.4. Home care
15.5.5. Others
15.6. Market Value Forecast By Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product & Service
15.7.2. By Technology
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Company Profiles
16.2.1. Danaher Corporation
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Product Portfolio
16.2.1.3. Financial Overview
16.2.1.4. SWOT Analysis
16.2.1.5. Strategic Overview
16.2.2. F. Hoffmann-La Roche Ltd.
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Product Portfolio
16.2.2.3. Financial Overview
16.2.2.4. SWOT Analysis
16.2.2.5. Strategic Overview
16.2.3. Thermo Fisher Scientific Inc.
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Product Portfolio
16.2.3.3. Financial Overview
16.2.3.4. SWOT Analysis
16.2.3.5. Strategic Overview
16.2.4. Becton, Dickinson, and Company
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Product Portfolio
16.2.4.3. Financial Overview
16.2.4.4. SWOT Analysis
16.2.4.5. Strategic Overview
16.2.5. QIAGEN N.V.
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. Financial Overview
16.2.5.4. SWOT Analysis
16.2.5.5. Strategic Overview
16.2.6. bioMérieux SA
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Product Portfolio
16.2.6.3. Financial Overview
16.2.6.4. SWOT Analysis
16.2.6.5. Strategic Overview
16.2.7. Siemens Healthcare GmbH
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Product Portfolio
16.2.7.3. Financial Overview
16.2.7.4. SWOT Analysis
16.2.7.5. Strategic Overview
16.2.8. Abbott Laboratories
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Product Portfolio
16.2.8.3. Financial Overview
16.2.8.4. SWOT Analysis
16.2.8.5. Strategic Overview
16.2.9. Agilent Technologies, Inc.
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. Financial Overview
16.2.9.4. SWOT Analysis
16.2.9.5. Strategic Overview
16.2.10. Bio-Rad Laboratories, Inc.
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Product Portfolio
16.2.10.3. Financial Overview
16.2.10.4. SWOT Analysis
16.2.10.5. Strategic Overview
16.2.11. Chembio Diagnostics, Inc.
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Product Portfolio
16.2.11.3. Financial Overview
16.2.11.4. SWOT Analysis
16.2.11.5. Strategic Overview
16.2.12. Sysmex Corporation
16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.12.2. Product Portfolio
16.2.12.3. Financial Overview
16.2.12.4. SWOT Analysis
16.2.12.5. Strategic Overview
16.2.13. QuidelOrtho Corporation.
16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.13.2. Product Portfolio
16.2.13.3. Financial Overview
16.2.13.4. SWOT Analysis
16.2.13.5. Strategic Overview
16.2.14. Illumina, Inc.
16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.14.2. Product Portfolio
16.2.14.3. Financial Overview
16.2.14.4. SWOT Analysis
16.2.14.5. Strategic Overview
List of Tables
Table 01: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
Table 02: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 03: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 04: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 06: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 07: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
Table 08: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 09: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031
Table 10: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031
Table 11: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031
Table 12: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 13: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 14: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 15: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
Table 16: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 17: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031
Table 18: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031
Table 19: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031
Table 20: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 21: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 22: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 23: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
Table 24: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 25: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031
Table 26: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031
Table 27: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031
Table 28: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 29: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 30: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 31: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
Table 32: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 33: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031
Table 34: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031
Table 35: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031
Table 36: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 37: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 38: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 39: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
Table 40: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 41: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031
Table 42: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031
Table 43: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031
Table 44: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 45: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global In Vitro Diagnostics Market Size, by Product & Service, 2022
Figure 02: In Vitro Diagnostics Market share (%), by Product & Service, 2022
Figure 03: In Vitro Diagnostics Market Size, by Technology, 2022
Figure 04: In Vitro Diagnostics Market share (%), by Technology, 2022
Figure 05: In Vitro Diagnostics Market Size, by Application, 2022
Figure 06: In Vitro Diagnostics Market share (%), by Application, 2022
Figure 07: In Vitro Diagnostics Market Size, by End-User, 2022
Figure 08: In Vitro Diagnostics Market share (%), by End-User, 2022
Figure 09: Global In Vitro Diagnostics Market, By Region (2022 and 2031)
Figure 10: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
Figure 11: Global In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031
Figure 12: Global In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022
Figure 13: Global In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2031
Figure 14: Global In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 15: Global In Vitro Diagnostics Market Value (US$ Mn), by Reagents & Kits, 2017-2031
Figure 16: Global In Vitro Diagnostics Market Value Share Analysis, by Reagents & Kits, 2022 and 2031
Figure 17: Global In Vitro Diagnostics Market Value (US$ Mn), by Instruments, 2017-2031
Figure 18: Global In Vitro Diagnostics Market Value Share Analysis, Instruments, 2022 and 2031
Figure 19: Global In Vitro Diagnostics Market Value (US$ Mn), by Software & Services, 2017-2031
Figure 20: Global In Vitro Diagnostics Market Value Share Analysis, by Software & Services, 2022 and 2031
Figure 21: Global In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031
Figure 22: Global In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022
Figure 23: Global In Vitro Diagnostics Market Value Share Analysis, by Technology, 2031
Figure 24: Global In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 25: Global In Vitro Diagnostics Market Value (US$ Mn), by Immunoassay, 2017-2031
Figure 26: Global In Vitro Diagnostics Market Value Share Analysis, by Immunoassay, 2022 and 2031
Figure 27: Global In Vitro Diagnostics Market Value (US$ Mn), by Clinical Chemistry, 2017-2031
Figure 28: Global In Vitro Diagnostics Market Value Share Analysis, Clinical Chemistry, 2022 and 2031
Figure 29: Global In Vitro Diagnostics Market Value (US$ Mn), by Molecular Diagnostics, 2017-2031
Figure 30: Global In Vitro Diagnostics Market Value Share Analysis, by Molecular Diagnostics, 2022 and 2031
Figure 31: Global In Vitro Diagnostics Market Value (US$ Mn), by Blood Glucose Monitoring, 2017-2031
Figure 32: Global In Vitro Diagnostics Market Value Share Analysis, Blood Glucose Monitoring, 2022 and 2031
Figure 33: Global In Vitro Diagnostics Market Value (US$ Mn), by Hematology, 2017-2031
Figure 34: Global In Vitro Diagnostics Market Value Share Analysis, by Molecular Diagnostics, 2022 and 2031
Figure 35: Global In Vitro Diagnostics Market Value (US$ Mn), by Others, 2017-2031
Figure 36: Global In Vitro Diagnostics Market Value Share Analysis, Blood Glucose Monitoring, 2022 and 2031
Figure 37: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 38: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2022
Figure 39: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2031
Figure 40: Global In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 41: Global In Vitro Diagnostics Market Value (US$ Mn), by Oncology, 2017-2031
Figure 42: Global In Vitro Diagnostics Market Value Share Analysis, by Oncology, 2022 and 2031
Figure 43: Global In Vitro Diagnostics Market Value (US$ Mn), by Infectious Diseases, 2017-2031
Figure 44: Global In Vitro Diagnostics Market Value Share Analysis, Infectious Diseases, 2022 and 2031
Figure 45: Global In Vitro Diagnostics Market Value (US$ Mn), by Metabolic Diseases, 2017-2031
Figure 46: Global In Vitro Diagnostics Market Value Share Analysis, by Metabolic Diseases, 2022 and 2031
Figure 47: Global In Vitro Diagnostics Market Value (US$ Mn), by Cardiology, 2017-2031
Figure 48: Global In Vitro Diagnostics Market Value Share Analysis, Cardiology, 2022 and 2031
Figure 49: Global In Vitro Diagnostics Market Value (US$ Mn), by Nephrology, 2017-2031
Figure 50: Global In Vitro Diagnostics Market Value Share Analysis, by Nephrology, 2022 and 2031
Figure 51 Global In Vitro Diagnostics Market Value (US$ Mn), by Drug Testing/Pharmacogenomics, 2017-2031
Figure 52: Global In Vitro Diagnostics Market Value Share Analysis, Drug Testing/pharmacogenomics, 2022 and 2031
Figure 53: Global In Vitro Diagnostics Market Value (US$ Mn), by Autoimmune Diseases, 2017-2031
Figure 54: Global In Vitro Diagnostics Market Value Share Analysis, by Autoimmune Diseases, 2022 and 2031
Figure 55: Global In Vitro Diagnostics Market Value (US$ Mn), by Others, 2017-2031
Figure 56: Global In Vitro Diagnostics Market Value Share Analysis, Others, 2022 and 2031
Figure 57: Global In Vitro Diagnostics Market Value Share Analysis, by End-User, 2022 and 2031
Figure 58: Global In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022
Figure 59: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2031
Figure 60: Global In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 61: Global In Vitro Diagnostics Market Value (US$ Mn), by Diagnostic Centers, 2017-2031
Figure 62: Global In Vitro Diagnostics Market Value Share Analysis, by Diagnostic Centers, 2022 and 2031
Figure 63: Global In Vitro Diagnostics Market Value (US$ Mn), by Hospital-based Laboratories, 2017-2031
Figure 64: Global In Vitro Diagnostics Market Value Share Analysis, Hospital-based Laboratories, 2022 and 2031
Figure 65: Global In Vitro Diagnostics Market Value (US$ Mn), by Academic & Research Institutes, 2017-2031
Figure 66: Global In Vitro Diagnostics Market Value Share Analysis, by Academic & Research Institutes, 2022 and 2031
Figure 67: Global In Vitro Diagnostics Market Value (US$ Mn), by Home care, 2017-2031
Figure 68: Global In Vitro Diagnostics Market Value Share Analysis, Home care, 2022 and 2031
Figure 69: Global In Vitro Diagnostics Market Value Share Analysis, by Region, 2022 and 2031
Figure 70: Global In Vitro Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
Figure 71: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 72: North America In Vitro Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
Figure 73: North America In Vitro Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
Figure 74: North America In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031
Figure 75: North America In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 76: North America In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031
Figure 77: North America In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
Figure 78: North America In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 79: North America In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 80: North America In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 81: North America In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 82: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 83: Europe In Vitro Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 84: Europe In Vitro Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 85: Europe In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031
Figure 86: Europe In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 87: Europe In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031
Figure 88: Europe In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
Figure 89: Europe In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 90: Europe In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 91: Europe In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 92: Europe In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 93: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 94: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 95: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 96: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031
Figure 97: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 98: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031
Figure 99: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
Figure 100: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 101: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 102: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 103: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 104: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 105: Latin America In Vitro Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 106: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 107: Latin America In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031
Figure 108: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 109: Latin America In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031
Figure 110: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
Figure 111: Latin America In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 112: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 113: Latin America In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 114: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 115: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 116: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 117: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 118: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031
Figure 119: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 120: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031
Figure 121: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
Figure 122: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 123: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 124: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 125: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
In Vitro Diagnostics Market